ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.
Leila KarimiSusanne J VijverbergMarjolein EngelkesNatalia Hernandez-PachecoNiloufar FarzanPatricia SoaresMaria Pino-YanesAndrea L JorgensenCeleste EngSomnath MukhopadhyayMaximilian SchieckMichael KabeschEsteban G BurchardFook Tim ChewYang Yie SioUroš PotočnikMario GorenjakDaniel B HawcuttColin N PalmerStephen W TurnerHettie M JanssensAnke H Maitland-van der ZeeKatia M C Verhammenull nullPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)
The ADRB2 Arg16 haplotype, presumably mainly driven by the Arg16, increased the risk of asthma exacerbations in patients treated with ICS plus LABA. This finding could be beneficial in ADRB2 genotype-guided treatment which might improve clinical outcomes in asthmatic patients.